24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
BiomX
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:40
Florida enthusiastically welcomes Calcalist conference to Miami
18:24
Bitsight acquires Cybersixgill in $115 million deal to strengthen cyber risk management
16:04
Full list of Israeli startup M&As in 2024
16:00
Immunai and Teva launch multi-tear AI collaboration for smarter drug development
More stories
Buzz
Most popular
Daily
Weekly
1
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
2
Is your solitaire opponent actually a bot?
3
Cloudera acquires Israeli startup Octopai to advance metadata and AI integration
4
Former Snyk founder Guy Podjarny secures $125M for AI-powered software startup Tessl
5
CyberArk and Wiz join forces to enhance cloud security in multi-cloud environments
More news
BiomX
3 stories about BiomX
Biomed Company BiomX Merges With New York-Listed Chardan Healthcare
17.07.19
|
Meir Orbach
BiomX develops customized therapies for conditions such as acne and inflammatory bowel disease
Phage Therapies Company BiomX Raises $32 Million
20.02.19
|
Amarelle Wenkert
BiomX develops customized therapies based on bacteriophages—viruses that invade bacterial cells and can be used to treat infections
Phage Therapies Company BiomX Signs Johnson & Johnson Collaboration
13.12.18
|
Lilach Baumer
Bacteriophages are viruses that invade bacterial cells and can be used to treat bacterial infections. Phage therapy is often discussed as an alternative to traditional antibiotics
Please ensure Javascript is enabled for purposes of
website accessibility